Oruka Therapeutics financials
$82.15−2.42%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q3 '24 Sep 30 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — |
| Operating income | -$50.1M | -$36.4M | -$34.4M | -$34.1M | -$28.4M | -$25.1M | -$29.4M |
| Net income | -$34.9M | -$31.8M | -$24.5M | -$24.0M | -$19.3M | -$21.0M | -$21.9M |
| Net margin | — | — | — | — | — | — | — |
| Diluted EPS | $-0.55 | $-0.48 | $-0.44 | $-0.55 | $-0.46 | $-0.40 | $-1.46 |
| EBITDA | -$50.1M | -$36.4M | -$34.4M | -$34.1M | -$28.4M | -$25.1M | -$29.4M |
| Operating cash flow | -$33.1M | -$23.6M | -$22.6M | -$21.6M | -$23.1M | -$20.9M | — |
| Free cash flow | -$33.1M | -$23.7M | -$22.7M | -$21.7M | -$23.2M | -$20.9M | — |
| Diluted shares | 62.9M | 55.2M | 55.2M | 44.1M | 42.1M | 41.7M | 15.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $268.5M | $49.5M | $46.9M | $91.3M | $65.4M | $83.6M |
| Short-term investments | $605.1M | $339.3M | $290.1M | $257.9M | $263.0M | $265.5M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.14B | $504.5M | $488.6M | $509.3M | $357.4M | $377.1M |
| Total liabilities | $24.8M | $17.8M | $16.7M | $22.5M | $13.8M | $12.4M |
| Shareholders' equity | $1.11B | $486.7M | $471.9M | $486.8M | $343.6M | $361.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology